"Enalaprilat" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The active metabolite of ENALAPRIL and a potent intravenously administered angiotensin-converting enzyme inhibitor. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.
Concept/Terms
Pres iv- Pres iv
- Boehringer Ingelheim Brand of Enalaprilat Anhydrous
Vasotec- Vasotec
- Biovail Brand of Enalaprilat Anhydrous
- Merck Frosst Brand of Enalaprilat Anhydrous
Xanef- Xanef
- MSD Brand of Enalaprilat
Below are MeSH descriptors whose meaning is more general than "Enalaprilat".
Below are MeSH descriptors whose meaning is more specific than "Enalaprilat".
This graph shows the total number of publications written about "Enalaprilat" by people in Harvard Catalyst Profiles by year, and whether "Enalaprilat" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 |
2000 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
Below are the most recent publications written about "Enalaprilat" by people in Profiles.
-
Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade. Hypertension. 2010 Feb; 55(2):298-304.
-
On call. I reread your articles on congestive heart failure when I was diagnosed with the condition last month. My breathing is back to normal, and I feel well. My doctor has prescribed all the medications you recommended, but he disagreed with one. He said that since I'm taking Vasotec, I should stop my aspirin. Do you agree? Harv Mens Health Watch. 2006 Feb; 10(7):8.
-
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol. 2005 Oct; 289(4):F880-90.
-
Angiotensin II contributes to arterial compliance in congestive heart failure. Am J Physiol Heart Circ Physiol. 2002 Oct; 283(4):H1424-9.
-
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation. 2002 Jun 11; 105(23):2785-90.
-
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem. 2002 May 10; 277(19):16847-52.
-
Effect of acute intravenous ace-inhibition on the intrarenal doppler flow characteristics in hypertensive patients with and without unilateral renal artery stenosis. Clin Exp Hypertens. 2000 Aug; 22(6):571-81.
-
Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension. AJR Am J Roentgenol. 2000 Feb; 174(2):499-508.
-
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clin Pharmacol Ther. 1999 Mar; 65(3):295-303.
-
Inhibition of angiotensin-converting enzyme in human hand veins. Clin Pharmacol Ther. 1999 Jan; 65(1):58-65.